2022-06-01 07258043 2023-05-31 07258043 2022-06-01 2023-05-31 07258043 uk-bus:RegisteredOffice 2022-06-01 2023-05-31 07258043 uk-bus:Director1 2022-06-01 2023-05-31 07258043 uk-bus:Director1 2023-05-31 07258043 2022-05-31 07258043 2021-06-01 2022-05-31 07258043 uk-core:WithinOneYear 2022-05-31 07258043 uk-core:WithinOneYear 2023-05-31 07258043 uk-core:AfterOneYear 2022-05-31 07258043 uk-core:AfterOneYear 2023-05-31 07258043 2023-05-31 07258043 2022-06-01 2023-05-31 07258043 2022-05-31 07258043 2021-06-01 2022-05-31 07258043 dpl-core:CostSales 2022-06-01 2023-05-31 07258043 dpl-core:AdministrativeExpenses 2022-06-01 2023-05-31 07258043 dpl-core:AdministrativeExpenses dpl-core:Item2 2022-06-01 2023-05-31 07258043 dpl-core:AdministrativeExpenses dpl-core:Item1 2022-06-01 2023-05-31 iso4217:GBP xbrli:pure 07258043 uk-bus:AuditExemptWithAccountantsReport 2022-06-01 2023-05-31 07258043 uk-bus:Micro-entities 2022-06-01 2023-05-31 07258043 uk-bus:FullAccounts 2022-06-01 2023-05-31 07258043 uk-bus:PrivateLimitedCompanyLtd 2022-06-01 2023-05-31
Podiatric Rx Limited
Registered Number:07258043
For the year ended 31 May 2023
England and Wales
Report of the Director and Unaudited Financial Statements
2
For the year ended 31 May 2023
Podiatric Rx Limited
Contents Page
Company Information
1
2
Director's Report
3
Independent Accountants' Report
4
Income Statement
5
Statement of Financial Position and Notes to the Accounts
6
Trading and Profit and Loss Account
3
For the year ended 31 May 2023
Podiatric Rx Limited
Company Information
Mr Mark Gallagher
Director
07258043
Registered Number
18 Lock Close
Registered Office
Stratford Upon Avon
United Kingdom
CV37 6GF
Powell & Associates
Accountants
Chartered Certified Accountants
28-29 New Road
Kidderminster
Worcestershire
DY10 1AF
1 of 6
4
For the year ended 31 May 2023
Podiatric Rx Limited
Director's Report
The director presents his report and financial statements for the year ended 31 May 2023.
Principal activities
The principal activity of the company continued to be that of podiatry.
Director
The director who served the company throughout the year was as follows:
Mr Mark Gallagher
Mr Mark Gallagher
Signed on behalf of the board of directors
This report has been prepared in accordance with the special provisions relating to small companies within Part 15 of the Companies Act 2006.
Date:
22 November 2023
2 of 6
5
For the year ended 31 May 2023
Podiatric Rx Limited
Independent Accountants' Report
Report to the director on the preparation of the unaudited statutory accounts of Podiatric Rx Limited for the
year ended 31 May 2023
In order to assist you to fulfil your duties under Companies Act 2006, we have prepared for your approval the accounts
of Podiatric Rx Limited for the year ended 31 May 2023 which comprise the Income Statement, the Statement of
Financial Position and the related notes from the company's accounting records and from information and
explanations you have given us.
As a practising firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other
professional requirements which are detailed at http://rulebook.accaglobal.com.
This report is made solely to the Board of Directors of Podiatric Rx Limited, as a body, in accordance with the terms of
our engagement letter dated 3 August 2021. Our work has been undertaken solely to prepare for your approval the
accounts of Podiatric Rx Limited and state those matters that we have agreed to state to the Board of Directors of
Podiatric Rx Limited, as a body, in this report in accordance with the requirements of the Association of Chartered
Certified Accountants and as detailed at http://www.accaglobal.com/factsheet163. To the fullest extent permitted by
law, we do not accept or assume responsibility to anyone other than Podiatric Rx Limited and its Board of Directors as
a body for our work or for this report.
It is your duty to ensure that Podiatric Rx Limited has kept adequate accounting records and to prepare statutory
accounts that give a true and fair view of the assets, liabilities, financial position and profit of Podiatric Rx Limited. You
consider that Podiatric Rx Limited is exempt from the statutory audit requirement for the year.
Powell & Associates
Managing Director
George Powell
Chartered Certified Accountants
28-29 New Road
Kidderminster
Worcestershire
DY10 1AF
Date:
22 November 2023
3 of 6
6
For the year ended 31 May 2023
Podiatric Rx Limited
Income Statement
2022
2023
£
£
Turnover
196,868
183,750
Staff costs
(57,625)
(47,676)
Depreciation and other amounts written off assets
(1,654)
(177)
Other charges
(99,472)
(85,682)
(7,355)
(8,189)
Tax
30,762
42,026
Profit for the financial year
4 of 6
7
07258043
Registered Number :
As at 31 May 2023
Podiatric Rx Limited
Statement of Financial Position and Notes to the Accounts
£
£
2022
2023
£
£
4,691
5,496
Fixed assets
8,739
22,250
Current assets
Creditors: amounts falling due
within one year
(9,084)
(8,555)
13,166
184
Net current assets
Total assets less current liabilities
4,875
18,662
Creditors: amounts falling due
after more than one year
(17,153)
(4,604)
271
Net assets
1,509
271
1,509
Capital and reserves
Notes to the Accounts
Statutory Information
Podiatric Rx Limited is a private limited company, limited by shares, domiciled in England and Wales, registration
number 07258043.
Registered address:
18 Lock Close
Stratford Upon Avon
United Kingdom
CV37 6GF
The presentation currency is £ sterling.
1. Average number of persons employed
During the year the average number of employees was 1 (2022 : 1)
For the year ended 31 May 2023 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2023 in accordance with Section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Section
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.
These financial statements have been prepared in accordance with the micro-entities provisions.
Mr Mark Gallagher
These financial statements were approved and authorised for issue by the Board on 22 November 2023 and were signed by:
5 of 6
8
For the year ended 31 May 2023
Podiatric Rx Limited
Trading and Profit and Loss Account
£
£
2022
2023
Turnover
183,750
196,868
Domestic Sales
Cost of Sales
27,217
21,417
Secretarial Fees
14,029
11,645
Room Hire
36,215
31,410
Direct Costs
(77,461)
(64,472)
119,407
Gross Profit
119,278
Administrative Expenses
27
501
Staff Training
9,096
8,866
Directors Salaries
48,502
38,309
Directors Pension Contributions
1,276
916
Accountancy Fees
13,586
13,821
Travel Expenses
125
90
Bank Charges
1,654
177
Depreciation Charge
2,728
2,626
Insurance
1,462
2,244
Computer Expenses
648
-
Website
125
35
Subscriptions
944
486
Printing, Stationery & Postage
1,002
796
Telecommunications
115
196
Sundry Expenses
(81,290)
(69,063)
Operating Profit
38,117
50,215
50,215
38,117
Profit before Taxation
6 of 6